Creatd, Inc. (CRTD)
CIK 1357671 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 3.3M shares as of Aug 12, 2026 (10-Q). Share count fell from 183.7M to 3.3M between Nov 14, 2023 and Aug 12, 2026, a pattern consistent with a reverse split (roughly 1-for-56); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Loan Agreement Warrants | 3,778 | $35 | — | FV $177,560 |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 13, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 2.0M underlying shares, as reported Jun 30, 2026 (10-Q).
Reported exercise price: $10 (aggregate figure as tagged; individual tranches vary).
Balance-sheet fair value of warrants: $3.2M as of Dec 31, 2022.
Rough fully diluted estimate: 5.3M = 3.3M O/S + 2.0M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| the First Tranche of Uplist Financing | not tagged | $1.6M | $10 | 0% | — |
| the Second Tranche of Uplist Financing | not tagged | $1.2M | $10 | 0% | — |
| the Third Tranche of Uplist Financing | not tagged | $375,000 | $10 | 0% | — |
| Uplisting Financing | $300,000 | $3.1M | $10 | 0% | ~30,000 sh |
| First April 2 Loan Agreement | $108,970 | $0 | $50 | 18% | ~2,179 sh |
| November 22 Loan Agreement | $30,000 | $0 | $20 | 18% | ~1,500 sh |
| First March 13 Loan Agreement | not tagged | $0 | $170 | 10%-18% | — |
If every note above converted at its tagged price: ~33,679 new shares on 3.3M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed Aug 13, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 3.3M | Aug 12, 2026 |
| + Loan Agreement Warrants (if exercised) | 3,778 | May 31, 2024 |
| + Uplisting Financing (if fully converted) | 30,000 | Jan 16, 2026 |
| + First April 2 Loan Agreement (if fully converted) | 2,179 | Oct 15, 2024 |
| + November 22 Loan Agreement (if fully converted) | 1,500 | Nov 22, 2024 |
| Fully diluted estimate | 3.3M | +1.1% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $13.1Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 0 executed · 5 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full CRTD workspace